HPV 16+ RECURRENT OR METASTATIC CANCER
Clinical trials for HPV 16+ RECURRENT OR METASTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HPV 16+ RECURRENT OR METASTATIC CANCER trials appear
Sign up with your email to follow new studies for HPV 16+ RECURRENT OR METASTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot tested for Tough-to-Treat HPV cancers
Disease control Recruiting nowThis is a very early study to check the safety and find the right dose of a new injection called TI-0093. It is for people with advanced head, neck, or cervical cancers linked to HPV-16 that have come back or spread after standard treatments. The main goals are to see what side e…
Matched conditions: HPV 16+ RECURRENT OR METASTATIC CANCER
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Family Members' immune cells tested to battle advanced HPV cancers
Disease control Recruiting nowThis early-stage study is testing whether immune cells from a patient's relative can help fight advanced cancers caused by HPV16. Relatives are vaccinated to boost their immune cells, which are then given to the cancer patient. Researchers are primarily checking if this approach …
Matched conditions: HPV 16+ RECURRENT OR METASTATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC